Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

P.M. Lykoudis; S. Partelli; F. Muffatti; M. Caplin; M. Falconi; G.K. Fusai; RARECAREnet working group; Silvia Giovanna Luisa Francisci; andrea tavilla; Daniela Pierannunzio; Silvia Rossi; Mariano Santaquilani; Arnold Knijn

doi:10.1016/j.ejso.2017.08.019

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

P.M. Lykoudis, S. Partelli, F. Muffatti, M. Caplin, M. Falconi, G.K. Fusai, RARECAREnet working group, Silvia Giovanna Luisa Francisci, andrea tavilla, Daniela Pierannunzio, Silvia Rossi, Mariano Santaquilani, Arnold Knijn

Istituto Superiore di Sanita'

Research output: Contribution to journal › Article › peer-review

Abstract

Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements. The specialized biochemical tests and radiological investigations, the complexity of surgical options and the variety of medical treatments that require individual tailoring, mandate a multidisciplinary approach that can be optimally achieved through an organized network. The present study describes currents concepts in the management of these tumours as well as an insight into the challenges of delivering the pathway in and outside a Network. © 2017 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology.

Original language	English
Journal	European Journal of Surgical Oncology
DOIs	https://doi.org/10.1016/j.ejso.2017.08.019
Publication status	Published - 2017

Keywords

Liver metastases
Neuroendocrine tumours
Pancreas
Rare cancers

Access to Document

10.1016/j.ejso.2017.08.019

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032974666&doi=10.1016%2fj.ejso.2017.08.019&partnerID=40&md5=56ac05f6605c8af8b61676ed51b3598d

Cite this

Lykoudis, P. M., Partelli, S., Muffatti, F., Caplin, M., Falconi, M., Fusai, G. K., group, RARECARE. W., Francisci, S. G. L., tavilla, A., Pierannunzio, D., Rossi, S., Santaquilani, M., & Knijn, A. (2017). Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2017.08.019

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. / Lykoudis, P.M.; Partelli, S.; Muffatti, F.; Caplin, M.; Falconi, M.; Fusai, G.K.; group, RARECAREnet working; Francisci, Silvia Giovanna Luisa ; tavilla, andrea ; Pierannunzio, Daniela ; Rossi, Silvia ; Santaquilani, Mariano; Knijn, Arnold.

In: European Journal of Surgical Oncology, 2017.

Research output: Contribution to journal › Article › peer-review

Lykoudis, P.M. ; Partelli, S. ; Muffatti, F. ; Caplin, M. ; Falconi, M. ; Fusai, G.K. ; group, RARECAREnet working ; Francisci, Silvia Giovanna Luisa ; tavilla, andrea ; Pierannunzio, Daniela ; Rossi, Silvia ; Santaquilani, Mariano ; Knijn, Arnold. / Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. In: European Journal of Surgical Oncology. 2017.

@article{89dfb3776b80463c9f3f14f7acc71938,

title = "Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours",

abstract = "Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements. The specialized biochemical tests and radiological investigations, the complexity of surgical options and the variety of medical treatments that require individual tailoring, mandate a multidisciplinary approach that can be optimally achieved through an organized network. The present study describes currents concepts in the management of these tumours as well as an insight into the challenges of delivering the pathway in and outside a Network. {\textcopyright} 2017 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology.",

keywords = "Liver metastases, Neuroendocrine tumours, Pancreas, Rare cancers",

author = "P.M. Lykoudis and S. Partelli and F. Muffatti and M. Caplin and M. Falconi and G.K. Fusai and group, {RARECAREnet working} and Francisci, {Silvia Giovanna Luisa} and andrea tavilla and Daniela Pierannunzio and Silvia Rossi and Mariano Santaquilani and Arnold Knijn",

note = "Export Date: 12 April 2018 Article in Press CODEN: EJSOE Correspondence Address: Lykoudis, P.M.email: p.lykoudis@ucl.ac.uk",

year = "2017",

doi = "10.1016/j.ejso.2017.08.019",

language = "English",

journal = "European Journal of Surgical Oncology",

issn = "0748-7983",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

AU - Lykoudis, P.M.

AU - Partelli, S.

AU - Muffatti, F.

AU - Caplin, M.

AU - Falconi, M.

AU - Fusai, G.K.

AU - group, RARECAREnet working

AU - Francisci, Silvia Giovanna Luisa

AU - tavilla, andrea

AU - Pierannunzio, Daniela

AU - Rossi, Silvia

AU - Santaquilani, Mariano

AU - Knijn, Arnold

N1 - Export Date: 12 April 2018 Article in Press CODEN: EJSOE Correspondence Address: Lykoudis, P.M.email: p.lykoudis@ucl.ac.uk

PY - 2017

Y1 - 2017

N2 - Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements. The specialized biochemical tests and radiological investigations, the complexity of surgical options and the variety of medical treatments that require individual tailoring, mandate a multidisciplinary approach that can be optimally achieved through an organized network. The present study describes currents concepts in the management of these tumours as well as an insight into the challenges of delivering the pathway in and outside a Network. © 2017 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology.

AB - Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements. The specialized biochemical tests and radiological investigations, the complexity of surgical options and the variety of medical treatments that require individual tailoring, mandate a multidisciplinary approach that can be optimally achieved through an organized network. The present study describes currents concepts in the management of these tumours as well as an insight into the challenges of delivering the pathway in and outside a Network. © 2017 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology.

KW - Liver metastases

KW - Neuroendocrine tumours

KW - Pancreas

KW - Rare cancers

U2 - 10.1016/j.ejso.2017.08.019

DO - 10.1016/j.ejso.2017.08.019

M3 - Article

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

ER -

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

Abstract

Keywords

Access to Document

Fingerprint

Cite this